MicroRNAs in colon cancer: A roadmap for discovery

FEBS Letters

Volumn 586, Issue 19, 2012, Pages 3000-3007

  Rossi, Simona ^a   Di Narzo, Antonio Fabio ^a   Mestdagh, Pieter ^b   Jacobs, Bart ^c   Bosman, Fredrik T ^d   Gustavsson, Bengt ^e   Majoie, Bernard ^f   Roth, Arnaud ^g   Vandesompele, Jo ^b   Rigoutsos, Isidore ^h   Delorenzi, Mauro ^a,i   Tejpar, Sabine ^c  

^a SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^b Biogazelle NV   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^f Fondation Fournier Majoie Pour l'Innovation   (Belgium)

^g GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^h THOMAS JEFFERSON UNIVERSITY   (United States)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Colon cancer; microRNA; Omic; Personalized medicine

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GEFITINIB; IRINOTECAN; MICRORNA; NANOPARTICLE; SMALL INTERFERING RNA;

CANCER DIAGNOSIS; CANCER GENE THERAPY; CANCER PROGNOSIS; CARCINOGENESIS; COLON CANCER; COLORECTAL CANCER; DISEASE ASSOCIATION; GENE DELIVERY SYSTEM; GENE MUTATION; HUMAN; MOLECULARLY TARGETED THERAPY; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE;

COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMPUTATIONAL BIOLOGY; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; PROGNOSIS; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84866616243     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2012.07.048     Document Type: Review

References (72)

1. J.S. Mattick, and I.V. Makunin Non-coding RNA Hum. Mol. Genet. 15 Spec No 1 2006 R17 29
2. A. Gorini, and G. Pravettoni P5 medicine: a plus for a personalized approach to oncology Nat. Rev. Clin. Oncol. 8 2011 444
3. S. Rossi, M. Christ-Neumann, S. Rüping, F. Buffa, D. Wegener, G. Mc Vie, P. Coveney, N. Graf, and M. Delorenzi p-Medicine: from data sharing and integration via VPH models to personalized medicine Ecancermedicalscience 5 2011 218
4. B. Gustavsson Simultaneous surgery for primary colorectal cancer and metastatic lesions? Scand. J. Gastroenterol. 47 2012 269 276
5. G.A. Calin, C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini, and C.M. Croce Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers Proc. Natl. Acad. Sci. U.S.A. 101 2004 2999 3004
6. L. Poliseno, L. Salmena, J. Zhang, B. Carver, W.J. Haveman, and P.P. Pandolfi A coding-independent function of gene and pseudogene mRNAs regulates tumour biology Nature 465 2010 1033 1038
7. A. Krek, D. Grün, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. MacMenamin, I. da Piedade, K.C. Gunsalus, M. Stoffel, and N. Rajewsky Combinatorial microRNA target predictions Nat. Genet. 37 2005 495 500
8. K.C. Miranda, T. Huynh, Y. Tay, Y.-S. Ang, W.-L. Tam, A.M. Thomson, B. Lim, and I. Rigoutsos A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes Cell 126 2006 1203 1217
9. J. Mattes, M. Yang, and P.S. Foster Regulation of microRNA by antagomirs: a new class of pharmacological antagonists for the specific regulation of gene function? Am. J. Respir. Cell Mol. Biol. 36 2007 8 12
10. Y. Tay, J. Zhang, A.M. Thomson, B. Lim, and I. Rigoutsos MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation Nature 455 2008 1124 1128
11. M.S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi, and G.A. Calin MicroRNAs - the micro steering wheel of tumour metastases Nat. Rev. Cancer 9 2009 293 302
12. A. Lujambio, and S.W. Lowe The microcosmos of cancer Nature 482 2012 347 355
13. F.T. Bosman, P. Yan, S. Tejpar, R. Fiocca, E. Van Cutsem, R.D. Kennedy, D. Dietrich, and A. Roth Tissue biomarker development in a multicentre trial context: a feasibility study on the PETACC3 stage II and III colon cancer adjuvant treatment trial Clin. Cancer Res. 15 2009 5528 5533
14. V. Popovici, E. Budinska, S. Tejpar, S. Weinrich, H. Estrella, G. Hodgson, E. Van Cutsem, T. Xie, F.T. Bosman, A.D. Roth, and M. Delorenzi Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer J. Clin. Oncol. 30 2012 1288 1295
15. Y. Xie, G. Xiao, K.R. Coombes, C. Behrens, L.M. Solis, G. Raso, L. Girard, H.S. Erickson, J. Roth, J.V. Heymach, C. Moran, K. Danenberg, J.D. Minna, and I.I. Wistuba Robust gene expression signature from formalin-fixed paraffin-embedded samples predicts prognosis of non-small-cell lung cancer patients Clin. Cancer Res. 17 2011 5705 5714
16. L. Weng, X. Wu, H. Gao, B. Mu, X. Li, J.-H. Wang, C. Guo, J.M. Jin, Z. Chen, M. Covarrubias, Y.-C. Yuan, L.M. Weiss, and H. Wu MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens J. Pathol. 222 2010 41 51
17. P.P. Reis, L. Waldron, R.S. Goswami, W. Xu, Y. Xuan, B. Perez-Ordonez, P. Gullane, J. Irish, I. Jurisica, and S. Kamel-Reid mRNA transcript quantification in archival samples using multiplexed, color-coded probes BMC Biotechnol. 11 2011 46
18. A. Ribeiro-Silva, H. Zhang, and S.S. Jeffrey RNA extraction from ten year old formalin-fixed paraffin-embedded breast cancer samples: a comparison of column purification and magnetic bead-based technologies BMC Mol. Biol. 8 2007 118
19. Bell, D.; Berchuck, A.; Birrer, M.; Chien, J.; Cramer, D.W.; Dao, F.; Dhir, R.; DiSaia, P.; Gabra, H.; Glenn, P.; Godwin, A.K.; Gross, J.; Hartmann, L.; Huang, M.; Huntsman, D.G.; Iacocca, M.; Imielinski, M.; Kalloger, S.; Karlan, B.Y.; Levine, D.A.; Mills, G.B.; Morrison, C.; Mutch, D.; Olvera, N.; Orsulic, S.; Park, K.; Petrelli, N.; Rabeno, B.; Rader, J.S.; Sikic, B.I.; Smith-McCune, K.; Sood, A.K.; Bowtell, D.; Penny, R.; Testa, J.R.; Chang, K.; Dinh, H.H.; Drummond, J.A.; Fowler, G.; Gunaratne, P.; Hawes, A.C.; Kovar, C.L.; Lewis, L.R.; Morgan, M.B.; Newsham, I.F.; Santibanez, J.; Reid, J.G.; Trevino, L.R.; Wu Y-Q.; Wang, M.; Muzny, D.M.; Wheeler, D.A.; Gibbs, R.A.; Getz, G.; Lawrence, M.S.; Cibulskis, K.; Sivachenko, A.Y.; Sougnez, C.; Voet, D.; Wilkinson, J.; Bloom, T.; Ardlie, K.; Fennell, T.; Baldwin, J.; Gabriel, S.; Lander, E.S.; Ding, L.; Fulton, R.S.; Koboldt, D.C.; McLellan, M.D.; Wylie, T.; Walker, J.; O'Laughlin, M.; Dooling, D.J.; Fulton, L.; Abbott, R.; Dees, N.D.; Zhang, Q.; Kandoth, C.; Wendl, M.; Schierding, W.; Shen, D.; Harris, C.C.; Schmidt, H.; Kalicki, J.; Delehaunty, K.D.; Fronick, C.C.; Demeter, R.; Cook, L.; Wallis, J.W.; Lin, L.; Magrini, V.J.; Hodges, J.S.; Eldred, J.M.; Smith, S.M.; Pohl, C.S.; Vandin, F.; Raphael, B.J.; Weinstock, G.M.; Mardis, E.R.; Wilson, R.K.; Meyerson, M.; Winckler, W.; Getz, G.; Verhaak, R.G.W.; Carter, S.L.; Mermel, C.H.; Saksena, G.; Nguyen, H.; Onofrio, R.C.; Lawrence, M.S.; Hubbard, D.; Gupta, S.; Crenshaw, A.; Ramos, A.H.; Ardlie, K.; Chin, L.; Protopopov, A.; Zhang, J.; Kim, T.M.; Perna, I.; Xiao, Y.; Zhang, H.; Ren, G.; Sathiamoorthy, N.; Park, R.W.; Lee, E.; Park, P.J.; Kucherlapati, R.; Absher, D.M.; Waite, L.; Sherlock, G.; Brooks, J.D.; Li, J.Z.; Xu, J.; Myers, R.M.; Laird, P.W.; Cope, L.; Herman, J.G.; Shen, H.; Weisenberger, D.J.; Noushmehr, H.; Pan, F.; Triche Jr, T.; Berman, B.P.; Van Den Berg, D.J.; Buckley, J.; Baylin, S.B.; Spellman, P.T.; Purdom, E.; Neuvial, P.; Bengtsson, H.; Jakkula, L.R.; Durinck, S.; Han, J.; Dorton, S.; Marr, H.; Choi, Y.G.; Wang, V.; Wang, N.J.; Ngai, J.; Conboy, J.G.; Parvin, B.; 13 Feiler, H.S.; Speed, T.P.; Gray, J.W.; Levine, D.A.; Socci, N.D.; Liang, Y.; Taylor, B.S.; Schultz, N.; Borsu, L.; Lash, A.E.; Brennan, C.; Viale, A.; Sander, C.; Ladanyi, M.; Hoadley, K.A.; Meng, S.; Du, Y.; Shi, Y.; Li, L.; Turman, Y.J.; Zang, D.; Helms, E.B.; Balu, S.; Zhou, X.; Wu, J.; Topal, M.D.; Hayes, D.N.; Perou, C.M.; Getz, G.; Voet, D.; Saksena, G.; Zhang, J.; Zhang, H.; Wu, C.J.; Shukla, S.; Cibulskis, K.; Lawrence, M.S.; Sivachenko, A.; Jing, R.; Park, R.W.; Liu, Y.; Park, P.J.; Noble, M.; Chin, L.; Carter, H.; Kim, D.; Karchin, R.; Spellman, P.T.; Purdom, E.; Neuvial, P.; Bengtsson, H.; Durinck, S.; Han, J.; Korkola, J.E.; Heiser, L.M.; Cho, R.J.; Hu, Z.; Parvin, B.; Speed, T.P.; Gray, J.W.; Schultz, N.; Cerami, E.; Taylor, B.S.; Olshen, A.; Reva, B.; Antipin, Y.; Shen, R.; Mankoo, P.; Sheridan, R.; Ciriello, G.; Chang, W.K.; Bernanke, J.A.; Borsu, L.; Levine, D.A.; Ladanyi, M.; Sander, C.; Haussler, D.; Benz, C.C.; Stuart, J.M.; Benz, S.C.; Sanborn, J.Z.; Vaske, C.J.; Zhu, J.; Szeto, C.; Scott, G.K.; Yau, C.; Hoadley, K.A.; Du, Y.; Balu, S.; Hayes, D.N.; Perou, C.M.; Wilkerson, M.D.; Zhang, N.; Akbani, R.; Baggerly, K.A.; Yung, W.K.; Mills, G.B.; Weinstein, J.N.; Penny, R.; Shelton, T.; Grimm, D.; Hatfield, M.; Morris, S.; Yena, P.; Rhodes, P.; Sherman, M.; Paulauskis, J.; Millis, S.; Kahn, A.; Greene, J.M.; Sfeir, R.; Jensen, M.A.; Chen, J.; Whitmore, J.; Alonso, S.; Jordan, J.; Chu, A.; Zhang, J.; Barker, A.; Compton, C.; Eley, G.; Ferguson, M.; Fielding, P.; Gerhard, D.S.; Myles, R.; Schaefer, C.; Mills Shaw, K.R.; Vaught, J.; Vockley, J.B.; Good, P.J.; Guyer, M.S.; Ozenberger, B.; Peterson, J. and Thomson, E. (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615.
20. K. Hur, Y. Toiyama, M. Takahashi, F. Balaguer, T. Nagasaka, J. Koike, H. Hemmi, M. Koi, C.R. Boland, and A. Goel MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis Gut 2012
21. S.A. Melo, and M. Esteller Dysregulation of microRNAs in cancer: playing with fire FEBS Lett. 585 2011 2087 2099
22. X. Luo, B. Burwinkel, S. Tao, and H. Brenner MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev. 20 2011 1272 1286
23. O. Slaby, M. Svoboda, P. Fabian, T. Smerdova, D. Knoflickova, M. Bednarikova, R. Nenutil, and R. Vyzula Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer Oncology 72 2007 397 402
24. J.-S. Gao, Y. Zhang, X. Tang, L.D. Tucker, P.M. Tarwater, P.J. Quesenberry, I. Rigoutsos, and B. Ramratnam The Evi1, microRNA-143, K-Ras axis in colon cancer FEBS Lett. 585 2011 693 699
25. A.J. Schetter, S.Y. Leung, J.J. Sohn, K.A. Zanetti, E.D. Bowman, N. Yanaihara, S.T. Yuen, T.L. Chan, D.L.W. Kwong, G.K.H. Au, C.-G. Liu, G.A. Calin, C.M. Croce, and C.C. Harris MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma JAMA 299 2008 425 436
26. A.J. Schetter, H. Okayama, and C.C. Harris The role of microRNAs in colorectal cancer Cancer J. 18 2012 244 252
27. E.K.O. Ng, W.W.S. Chong, H. Jin, E.K.Y. Lam, V.Y. Shin, J. Yu, T.C.W. Poon, S.S.M. Ng, and J.J.Y. Sung Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening Gut 58 2009 1375 1381
28. L.-G. Wang, and J. Gu Serum microRNA-29a is a promising novel marker for early detection of colorectal liver metastasis Cancer Epidemiol. 36 2012 e61 67
29. Y. Ma, P. Zhang, F. Wang, H. Zhang, J. Yang, J. Peng, W. Liu, and H. Qin miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer Gut 2011
30. C. Vasilescu, S. Rossi, M. Shimizu, S. Tudor, A. Veronese, M. Ferracin, M.S. Nicoloso, E. Barbarotto, M. Popa, O. Stanciulea, M.H. Fernandez, D. Tulbure, C.E. Bueso-Ramos, M. Negrini, and G.A. Calin MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis PLoS ONE 4P 2009 e7405
31. J.S.L. Earle, R. Luthra, A. Romans, R. Abraham, J. Ensor, H. Yao, and S.R. Hamilton Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma J. Mol. Diagn. 12 2010 433 440
32. G. Lanza, M. Ferracin, R. Gafà, A. Veronese, R. Spizzo, F. Pichiorri, C. Liu, G.A. Calin, C.M. Croce, and M. Negrini mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer Mol. Cancer 6 2007 54
33. R. Nagel, C. le Sage, B. Diosdado, M. van der Waal, J.A.F. Oude Vrielink, A. Bolijn, G.A. Meijer, and R. Agami Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer Cancer Res. 68 2008 5795 5802
34. S. Volinia, M. Galasso, S. Costinean, L. Tagliavini, G. Gamberoni, A. Drusco, J. Marchesini, N. Mascellani, M.E. Sana, R. Abu Jarour, C. Desponts, M. Teitell, R. Baffa, R. Aqeilan, M.V. Iorio, C. Taccioli, R. Garzon, G. Di Leva, M. Fabbri, M. Catozzi, M. Previati, S. Ambs, T. Palumbo, M. Garofalo, A. Veronese, A. Bottoni, P. Gasparini, C.C. Harris, R. Visone, Y. Pekarsky, A. de la Chapelle, M. Bloomston, M. Dillhoff, L.Z. Rassenti, T.J. Kipps, K. Huebner, F. Pichiorri, D. Lenze, S. Cairo, M.-A. Buendia, P. Pineau, A. Dejean, N. Zanesi, S. Rossi, G.A. Calin, C.-G. Liu, J. Palatini, M. Negrini, A. Vecchione, A. Rosenberg, and C.M. Croce Reprogramming of miRNA networks in cancer and leukemia Genome Res. 20 2010 589 599
35. P. Roepman, J. Jassem, E.F. Smit, T. Muley, J. Niklinski, T. van de Velde, A.T. Witteveen, W. Rzyman, A. Floore, S. Burgers, G. Giaccone, M. Meister, H. Dienemann, M. Skrzypski, M. Kozlowski, W.J. Mooi, and N. van Zandwijk An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer Clin. Cancer Res. 15 2009 284 290
36. X. Chen, X. Guo, H. Zhang, Y. Xiang, J. Chen, Y. Yin, X. Cai, K. Wang, G. Wang, Y. Ba, L. Zhu, J. Wang, R. Yang, Y. Zhang, Z. Ren, K. Zen, J. Zhang, and C.-Y. Zhang Role of miR-143 targeting KRAS in colorectal tumorigenesis Oncogene 28 2009 1385 1392
37. T.A. Yap, M. Gerlinger, P.A. Futreal, L. Pusztai, and C. Swanton Intratumor heterogeneity: seeing the wood for the trees Sci. Transl. Med. 4 2012 127ps10
38. K.A. Baggerly, and K.R. Coombes What information should be required to support clinical "Omics" publications? Clin. Chem. 2011
39. M. Wu, N. Jolicoeur, Z. Li, L. Zhang, Y. Fortin, D. L'Abbe, Z. Yu, and S.-H. Shen Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs Carcinogenesis 29 2008 1710 1716
40. M. Kalimutho, G. Del Vecchio Blanco, S. Di Cecilia, P. Sileri, M. Cretella, F. Pallone, G. Federici, and S. Bernardini Differential expression of miR-144 as a novel fecal-based diagnostic marker for colorectal cancer J. Gastroenterol. 46 2011 1391 1402
41. F. Graziano, E. Canestrari, F. Loupakis, A. Ruzzo, N. Galluccio, D. Santini, M. Rocchi, B. Vincenzi, L. Salvatore, C. Cremolini, C. Spoto, V. Catalano, S. D'Emidio, P. Giordani, G. Tonini, A. Falcone, and M. Magnani Genetic modulation of the Let-7 microRNA binding to KRAS 3'-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab-irinotecan Pharmacogenomics J. 10 2010 458 464
42. A. Ruzzo, F. Graziano, B. Vincenzi, E. Canestrari, G. Perrone, N. Galluccio, V. Catalano, F. Loupakis, C. Rabitti, D. Santini, G. Tonini, G. Fiorentini, D. Rossi, A. Falcone, and M. Magnani High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease Oncologist 17 2012 823 829
43. M. Pichler, E. Winter, M. Stotz, K. Eberhard, H. Samonigg, S. Lax, and G. Hoefler Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer Br. J. Cancer 106 2012 1826 1832
44. C.J. Allegra, J.M. Jessup, M.R. Somerfield, S.R. Hamilton, E.H. Hammond, D.F. Hayes, P.K. McAllister, R.F. Morton, and R.L. Schilsky American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy J. Clin. Oncol. 27 2009 2091 2096
45. A. Bardelli, and S. Siena Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer J. Clin. Oncol. 28 2010 1254 1261
46. A.N. Bartley, H. Yao, B.A. Barkoh, C. Ivan, B.M. Mishra, A. Rashid, G.A. Calin, R. Luthra, and S.R. Hamilton Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer Clin. Cancer Res. 17 2011 7283 7293
47. M.I. Almeida, M.S. Nicoloso, L. Zeng, C. Ivan, R. Spizzo, R. Gafà, L. Xiao, X. Zhang, I. Vannini, F. Fanini, M. Fabbri, G. Lanza, R.M. Reis, P.A. Zweidler-McKay, and G.A. Calin Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells Gastroenterology 142 2012 886 896
48. B. D'haene, P. Mestdagh, J. Hellemans, and J. Vandesompele miRNA expression profiling: from reference genes to global mean normalization Methods Mol. Biol. 822 2012 261 272
49. M. Garofalo, G. Romano, G. Di Leva, G. Nuovo, Y.-J. Jeon, A. Ngankeu, J. Sun, F. Lovat, H. Alder, G. Condorelli, J.A. Engelman, M. Ono, J.K. Rho, L. Cascione, S. Volinia, K.P. Nephew, and C.M. Croce EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers Nat. Med. 18 2011 74 82
50. M.E. Davis, J.E. Zuckerman, C.H.J. Choi, D. Seligson, A. Tolcher, C.A. Alabi, Y. Yen, J.D. Heidel, and A. Ribas Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 2010 1067 1070
51. Y. Akao, Y. Nakagawa, and T. Naoe let-7 microRNA functions as a potential growth suppressor in human colon cancer cells Biol. Pharm. Bull. 29 2006 903 906
52. A. Lujambio, S. Ropero, E. Ballestar, M.F. Fraga, C. Cerrato, F. Setién, S. Casado, A. Suarez-Gauthier, M. Sanchez-Cespedes, A. Git, A. Gitt, I. Spiteri, P.P. Das, C. Caldas, E. Miska, and M. Esteller Genetic unmasking of an epigenetically silenced microRNA in human cancer cells Cancer Res. 67 2007 1424 1429
53. C. Guo, J.F. Sah, L. Beard, J.K.V. Willson, S.D. Markowitz, and K. Guda The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers Genes Chromosomes Cancer 47 2008 939 946
54. Y. Saito, G. Liang, G. Egger, J.M. Friedman, J.C. Chuang, G.A. Coetzee, and P.A. Jones Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells Cancer Cell 9 2006 435 443
55. B. Song, Y. Wang, Y. Xi, K. Kudo, S. Bruheim, G.I. Botchkina, E. Gavin, Y. Wan, A. Formentini, M. Kornmann, O. Fodstad, and J. Ju Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells Oncogene 28 2009 4065 4074
56. M. Hu, M. Xia, X. Chen, Z. Lin, Y. Xu, Y. Ma, and L. Su MicroRNA-141 regulates Smad interacting protein 1 (SIP1) and inhibits migration and invasion of colorectal cancer cells Dig. Dis. Sci. 55 2010 2365 2372
57. Y. Akao, Y. Nakagawa, and T. Naoe MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers Oncol. Rep. 16 2006 845 850
58. E.K.O. Ng, W.P. Tsang, S.S.M. Ng, H.C. Jin, J. Yu, J.J. Li, C. Röcken, M.P.A. Ebert, T.T. Kwok, and J.J.Y. Sung MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer Br. J. Cancer 101 2009 699 706
59. G. La Rocca, M. Badin, B. Shi, S.-Q. Xu, T. Deangelis, L. Sepp-Lorenzinoi, and R. Baserga Mechanism of growth inhibition by MicroRNA 145: the role of the IGF-I receptor signaling pathway J. Cell. Physiol. 220 2009 485 491
60. B. Shi, L. Sepp-Lorenzino, M. Prisco, P. Linsley, T. deAngelis, and R. Baserga Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells J. Biol. Chem. 282 2007 32582 32590
61. T. Schepeler, J.T. Reinert, M.S. Ostenfeld, L.L. Christensen, A.N. Silahtaroglu, L. Dyrskjot, C. Wiuf, F.J. Sorensen, M. Kruhoffer, S. Laurberg, S. Kauppinen, T.F. Orntoft, and C.L. Andersen Diagnostic and prognostic microRNAs in stage II colon cancer Cancer Res. 68 2008 6416 6424
62. M. Dews, A. Homayouni, D. Yu, D. Murphy, C. Sevignani, E. Wentzel, E.E. Furth, W.M. Lee, G.H. Enders, J.T. Mendell, and A. Thomas-Tikhonenko Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster Nat. Genet. 38 2006 1060 1065
63. W.P. Tsang, and T.T. Kwok The miR-18a microRNA functions as a potential tumor suppressor by targeting on K-Ras Carcinogenesis 30 2009 953 959
64. C.J. Braun, X. Zhang, I. Savelyeva, S. Wolff, U.M. Moll, T. Schepeler, T.F. Orntoft, C.L. Andersen, and M. Dobbelstein p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest Cancer Res. 68 2008 10094 10104
65. C.C. Schimanski, K. Frerichs, F. Rahman, M. Berger, H. Lang, P.R. Galle, M. Moehler, and I. Gockel High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells World J. Gastroenterol. 15 2009 2089 2096
66. P. Wang, F. Zou, X. Zhang, H. Li, A. Dulak, R.J. Tomko Jr.; J.S. Lazo, Z. Wang, L. Zhang, and J. Yu microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells Cancer Res. 69 2009 8157 8165
67. I.A. Asangani, S.A.K. Rasheed, D.A. Nikolova, J.H. Leupold, N.H. Colburn, S. Post, and H. Allgayer MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer Oncogene 27 2008 2128 2136
68. U. Burk, J. Schubert, U. Wellner, O. Schmalhofer, E. Vincan, S. Spaderna, and T. Brabletz A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells EMBO Rep. 9 2008 582 589
69. W.M. Grady, R.K. Parkin, P.S. Mitchell, J.H. Lee, Y.-H. Kim, K.D. Tsuchiya, M.K. Washington, C. Paraskeva, J.K.V. Willson, A.M. Kaz, E.M. Kroh, A. Allen, B.R. Fritz, S.D. Markowitz, and M. Tewari Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer Oncogene 27 2008 3880 3888
70. H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells Proc. Natl. Acad. Sci. U.S.A. 104 2007 15472 15477
71. M. Toyota, H. Suzuki, Y. Sasaki, R. Maruyama, K. Imai, Y. Shinomura, and T. Tokino Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer Cancer Res. 68 2008 4123 4132
72. E. Bandres, N. Bitarte, F. Arias, J. Agorreta, P. Fortes, X. Agirre, R. Zarate, J.A. Diaz-Gonzalez, N. Ramirez, J.J. Sola, P. Jimenez, J. Rodriguez, and J. Garcia-Foncillas microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells Clin. Cancer Res. 15 2009 2281 2290